Media Library
icon
-
ImagelockManufacturing / ImageNovartis radioligand therapy (RLT) manufacturing facilityExterior view of our large-scale, state-of-the-art radioligand therapy (RLT) manufacturing facility in Indianapolis, Indiana, United States.
-
ImagelockManufacturing / ImageRadioligand therapy (RLT) production lineHighly trained specialists on the production line of our radioligand therapy (RLT) manufacturing facility in Indianapolis, Indiana, United States.
-
ImagelockManufacturing / ImageRefrigeration room at a Novartis radioligand therapy (RLT) manufacturing facilityExamining materials inside the refrigeration room of our radioligand therapy (RLT) manufacturing facility in Indianapolis, Indiana, United States.
-
ImagelockManufacturing / ImageSpecialized equipment for the manufacture of radioligand therapy (RLT)Using specialized equipment on the production line at our radioligand therapy (RLT) manufacturing facility in Indianapolis, Indiana, United States.
-
ImagelockManufacturing / ImageQuality control for environmental monitoring in radioligand therapy (RLT) manufacturingConducting quality control at our state-of-the-art radioligand therapy (RLT) manufacturing facility in Indianapolis, Indiana, United States.
-
ImagelockLeadership / ImagePatrick Horber, M.D.President, International, since December 1, 2023
-
ImagelockLeadership / ImagePatrick Horber, M.D.President, International, since December 1, 2023
-
ImagelockLeadership / ImagePatrick Horber, M.D.President, International, since December 1, 2023
-
ImagelockLeadership / ImagePatrick Horber, M.D.President, International, since December 1, 2023
-
ImagelockLeadership / ImageMichelle WeeseChief Corporate Affairs Officer
-
ImagelockLeadership / ImageKaren L. HaleChief Legal Officer
-
ImagelockLeadership / ImageKaren L. HaleChief Legal Officer
Pagination
- ‹ Previous page
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- …
- 14
- › Next page